Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

ClinicalTrials.gov ID: NCT00004054

Public ClinicalTrials.gov record NCT00004054. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 3:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Protocol of Androgen Suppression (AS) and Radiation Therapy (RT) vs AS and RT Followed by Chemotherapy With Paclitaxel, Estramustine, and Etoposide (TEE) for Localized, High-Risk, Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Hormones can stimulate the production of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens. Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether hormone therapy plus radiation therapy is more effective with or without combination chemotherapy for prostate cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of hormone therapy plus radiation therapy with or without combination chemotherapy in treating patients who have prostate cancer.

Study identification

NCT ID
NCT00004054
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
397 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2000 (Type not available)
Primary completion
Apr 2010 (Actual)
Completion
Nov 2013 (Actual)
Last update posted
Oct 22, 2020

2000 – 2013

United States locations

U.S. sites
52
U.S. states
22
U.S. cities
46
Facility City State ZIP Site status
University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama 35294-3300 —
Foundation for Cancer Research and Education Phoenix Arizona 85013 —
Mount Diablo Medical Center Concord California 94524-4110 —
Sutter Health Western Division Cancer Research Group Greenbrae California 94904 —
CCOP - Santa Rosa Memorial Hospital Santa Rosa California 95403 —
University of Colorado Cancer Center at University of Colorado Health Sciences Center Denver Colorado 80010 —
Baptist Hospital of Miami Miami Florida 33176-2197 —
Lutheran General Cancer Care Center Park Ridge Illinois 60068 —
Methodist Cancer Center at Methodist Hospital Indianapolis Indiana 46206-1367 —
Ball Memorial Hospital Cancer Center Muncie Indiana 47303-3499 —
Markey Cancer Center at University of Kentucky Chandler Medical Center Lexington Kentucky 40536-0293 —
Mary Bird Perkins Cancer Center Baton Rouge Louisiana 70809 —
CCOP - Ochsner New Orleans Louisiana 70121 —
Anne Arundel Oncology Center Annapolis Maryland 21401 —
Greater Baltimore Medical Center and Cancer Center Baltimore Maryland 21204 —
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-0010 —
West Michigan Cancer Center Kalamazoo Michigan 49007 —
Marquette General Hospital Marquette Michigan 49855 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri 65203 —
CCOP - Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
Veterans Affairs Medical Center - East Orange East Orange New Jersey 07019 —
Monmouth Medical Center Long Branch New Jersey 07740-6395 —
South Jersey Regional Cancer Center Millville New Jersey 08332 —
Atlantic City Medical Center Pomona New Jersey 08240 —
Fox Chase Cancer Center at St. Francis Medical Center Trenton New Jersey 08629 —
CCOP - North Shore University Hospital Manhasset New York 11030 —
Herbert Irving Comprehensive Cancer Center at Columbia University New York New York 10032 —
Akron General Medical Center Akron Ohio 44302 —
Akron City Hospital Akron Ohio 44304 —
CCOP - Columbus Columbus Ohio 43206 —
Arthur G. James Cancer Hospital - Ohio State University Columbus Ohio 43210-1240 —
CCOP - Dayton Dayton Ohio 45429 —
CCOP - Toledo Community Hospital Toledo Ohio 43623-3456 —
John and Dorothy Morgan Cancer Center at Lehigh Valley Hospital Allentown Pennsylvania 18105 —
St. Luke's Hospital Cancer Center Bethlehem Pennsylvania 18015 —
Delaware County Memorial Hospital Drexel Hill Pennsylvania 19026 —
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia Philadelphia Pennsylvania 19107-5541 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
Albert Einstein Cancer Center Philadelphia Pennsylvania 19141-3098 —
CCOP - MainLine Health Wynnewood Pennsylvania 19096 —
Wellspan Health - York Cancer Center York Pennsylvania 17403 —
University of Texas - MD Anderson Cancer Center Houston Texas 77030-4009 —
LDS Hospital Salt Lake City Utah 84143 —
Dixie Regional Medical Center St. George Utah 84770 —
University Cancer Center at University of Washington Medical Center Seattle Washington 98195-6043 —
CCOP - St. Vincent Hospital Cancer Center, Green Bay Green Bay Wisconsin 54301 —
St. Vincent Hospital Green Bay Wisconsin 54307-3508 —
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center La Crosse Wisconsin 54601 —
St. Luke's Medical Center Milwaukee Wisconsin 53215 —
Medical College of Wisconsin Cancer Center Milwaukee Wisconsin 53226 —
All Saints Cancer Center at All Saints Healthcare Racine Wisconsin 53405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00004054, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2020 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00004054 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →